An international team led by Jonathan F. Lovell, PhD, assistant professor of biomedical engineering, has created a nanoparticle that may pave the way for “hypermodal” imaging — the ability to merge results from six different imaging modes using one contrast agent.
University at Buffalo researchers have designed a biomedical device that could make chemotherapy more efficient, reduce its side effects and improve how doctors treat some of the most deadly forms of cancer.
With the goal of improving chemotherapy, Jennifer A. Surtees, PhD, associate professor of biochemistry, will study what makes cancer cells sensitive or resistant to different DNA-damaging drugs.
A University at Buffalo biochemist led the first study to identify the liver kinase B1 (LKB1) pathway as a possible therapeutic target for neuropathies, including diabetic neuropathy.
Alan J. Lesse, MD, and John A. Sellick Jr., DO, associate professors of medicine in the Division of Infectious Diseases, presented the latest information about the Ebola virus outbreak at a Mini Medical School lecture, a free public talk.
Anne B. Curtis, MD, Charles and Mary Bauer Professor and chair of medicine, says patients with coronary heart disease and heart failure should not overexert themselves while engaging in cold-weather tasks, such as clearing snow.
“We have no reason to fear Ebola here in the United States, but the situation in West Africa is a grave humanitarian crisis,” Myron L. Glick, MD, told a standing room-only crowd of University at Buffalo medical students and residents shortly after returning from Sierra Leone.
Nearly one-third of adults in and around Fontaine, Haiti, suffer from hypertension, according to a pilot research project led by second-year University at Buffalo medical student Vincenzo Polsinelli.
University at Buffalo Tar Wars volunteers, including medical students, are visiting fourth- and fifth-grade classrooms in Western New York, armed with important lessons about the dangers of smoking.
Males with irritable bowel syndrome (IBS) experience more interpersonal difficulties than do females with the condition, according to research by Jeffrey M. Lackner, PsyD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition.
Researchers in the University at Buffalo’s Department of Medicine have been awarded a patent for a test that allows physicians to diagnose the autoimmune disease Sjogren’s syndrome earlier than ever before.
The nonprofit Lighthouse Free Medical Clinic — where University at Buffalo medical students care for uninsured patients — hosted an art opening to promote their services and provide health care information.
Federal approval of new drugs to treat the hepatitis C virus (HCV) represents “a dramatic, positive development for patients,” says University at Buffalo liver disease expert Andrew H. Talal, MD.
A drug developed by University at Buffalo scientists from a small protein found in spider venom is moving forward as a promising treatment for Duchenne muscular dystrophy, a fatal genetic disease affecting boys.
University at Buffalo researchers have helped discover a sleep-promoting circuit in the brainstem, revealing how we fall into deep sleep — findings that may lead to new therapies for sleep disorders.
University at Buffalo researchers have confirmed that the inexpensive, non-invasive Lung Flute offers an array of benefits — including improved symptoms — for COPD patients with chronic bronchitis.
University at Buffalo researchers are part of a multidisciplinary team using innovative techniques to reveal mechanisms of autoimmune disease pathology at the nanoscale level.
Research by David Dietz, PhD, has the potential to identify novel therapies to treat addiction to cocaine and other psychostimulants, for which no effective drug therapy exists.
